EMA Authorised: Tolvaptan Accord (tolvaptan) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Tolvaptan Accord for the treatment of Syndrome of inappropriate antidiuretic hormone secretion (SIADH); Accord Healthcare S.L.U. is the marke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• Tolvaptan Accord (tolvaptan)

Snippet

Status: Authorised. Therapeutic area: Inappropriate ADH Syndrome. MAH: Accord Healthcare S.L.U.. Decision date: 09/01/2026